← Browse by Condition
Medical Condition
stage iii breast cancer
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2
NCT04553770 Phase 2
Recruiting
Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
Enrollment
88 pts
Location
United States
Sponsor
Jonsson Comprehensive Cancer C...
NCT07314073 Phase 2
Recruiting
[18F]FES PET/CT for the Detection of Distant Metastasis in Low-grade ER-positive Stage III Breast Cancer
Enrollment
85 pts
Location
South Korea
Sponsor
Asan Medical Center
NCT07095114
Recruiting
A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.
Enrollment
30 pts
Location
United States
Sponsor
Barbara Ann Karmanos Cancer In...